Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:37:34 +0200Mon, 15 Jul 2024 14:26:00 +0200Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/idefirixHuman medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/idefirixMon, 15 Jul 2024 14:26:00 +0200Human medicineIdefirix : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4849_en_2.pdfIdefirix : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4849_en_2.pdfMon, 15 Jul 2024 14:23:00 +0200Human medicine